Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

[A suspected carcinoma finding in the uterus].

Kahl P, Quakernack J, Kuhnen C.

Pathologe. 2019 Jul;40(4):455-456. doi: 10.1007/s00292-019-0587-2. German.

PMID:
30968191
2.

Exome sequencing characterizes the somatic mutation spectrum of early serrated lesions in a patient with serrated polyposis syndrome (SPS).

Horpaopan S, Kirfel J, Peters S, Kloth M, Hüneburg R, Altmüller J, Drichel D, Odenthal M, Kristiansen G, Strassburg C, Nattermann J, Hoffmann P, Nürnberg P, Büttner R, Thiele H, Kahl P, Spier I, Aretz S.

Hered Cancer Clin Pract. 2017 Nov 29;15:22. doi: 10.1186/s13053-017-0082-9. eCollection 2017.

3.

Imaging the Nonlinear Plasmoemission Dynamics of Electrons from Strong Plasmonic Fields.

Podbiel D, Kahl P, Makris A, Frank B, Sindermann S, Davis TJ, Giessen H, Hoegen MH, Meyer Zu Heringdorf FJ.

Nano Lett. 2017 Nov 8;17(11):6569-6574. doi: 10.1021/acs.nanolett.7b02235. Epub 2017 Oct 4.

PMID:
28945435
4.

Short-range surface plasmonics: Localized electron emission dynamics from a 60-nm spot on an atomically flat single-crystalline gold surface.

Frank B, Kahl P, Podbiel D, Spektor G, Orenstein M, Fu L, Weiss T, Horn-von Hoegen M, Davis TJ, Meyer Zu Heringdorf FJ, Giessen H.

Sci Adv. 2017 Jul 12;3(7):e1700721. doi: 10.1126/sciadv.1700721. eCollection 2017 Jul.

5.

Revealing the subfemtosecond dynamics of orbital angular momentum in nanoplasmonic vortices.

Spektor G, Kilbane D, Mahro AK, Frank B, Ristok S, Gal L, Kahl P, Podbiel D, Mathias S, Giessen H, Meyer Zu Heringdorf FJ, Orenstein M, Aeschlimann M.

Science. 2017 Mar 17;355(6330):1187-1191. doi: 10.1126/science.aaj1699. Epub 2017 Mar 16.

PMID:
28302854
6.

[2](1,3)Adamantano[2](2,7)pyrenophane: A Hydrocarbon with a Large Dipole Moment.

Kahl P, Wagner JP, Balestrieri C, Becker J, Hausmann H, Bodwell GJ, Schreiner PR.

Angew Chem Int Ed Engl. 2016 Aug 1;55(32):9277-81. doi: 10.1002/anie.201602201. Epub 2016 Jul 1.

PMID:
27364983
7.

Actinic keratosis: correlation between clinical and histological classification systems.

Schmitz L, Kahl P, Majores M, Bierhoff E, Stockfleth E, Dirschka T.

J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1303-7. doi: 10.1111/jdv.13626. Epub 2016 Mar 8.

PMID:
26955898
8.

Bringing to Light Hidden Elasticity in the Liquid State Using In-Situ Pretransitional Liquid Crystal Swarms.

Kahl P, Baroni P, Noirez L.

PLoS One. 2016 Feb 4;11(2):e0147914. doi: 10.1371/journal.pone.0147914. eCollection 2016.

9.

Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.

Adam AC, Scriba A, Ortmann M, Huss S, Kahl P, Steiner S, Störkel S, Büttner R.

Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):54-9. doi: 10.1097/PAI.0000000000000036.

PMID:
25265428
10.

Hidden solidlike properties in the isotropic phase of the 8CB liquid crystal.

Kahl P, Baroni P, Noirez L.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Nov;88(5):050501. Epub 2013 Nov 6.

PMID:
24329199
11.

High latency of tuberculosis manifestation in a premature extremely low birth weight infant with favorable outcome.

Vogel M, Schroten H, Kahl P, Müller A.

Neonatology. 2014;105(2):91-4. doi: 10.1159/000355538. Epub 2013 Nov 28.

PMID:
24296485
12.

Oral CPSI-2364 treatment prevents postoperative ileus in swine without impairment of anastomotic healing.

Vilz TO, Sommer N, Kahl P, Pantelis D, Kalff JC, Wehner S.

Cell Physiol Biochem. 2013;32(5):1362-73. doi: 10.1159/000356575. Epub 2013 Nov 22.

13.

Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model.

König K, Meder L, Kröger C, Diehl L, Florin A, Rommerscheidt-Fuss U, Kahl P, Wardelmann E, Magin TM, Buettner R, Heukamp LC.

PLoS One. 2013;8(3):e57996. doi: 10.1371/journal.pone.0057996. Epub 2013 Mar 11.

14.

Histone methylation defines an epigenetic entity in penile squamous cell carcinoma.

Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF, Hofstädter F, Kristiansen G, von Ruecker A, Müller SC, Ellinger J.

J Urol. 2013 Mar;189(3):1117-22. doi: 10.1016/j.juro.2012.08.221. Epub 2012 Oct 8.

PMID:
22999995
15.

Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.

Hamprecht A, Buchheidt D, Vehreschild JJ, Cornely OA, Spiess B, Plum G, Halbsguth TV, Kutsch N, Stippel D, Kahl P, Persigehl T, Steinbach A, Bos B, Hallek M, Vehreschild MJ.

Euro Surveill. 2012 Sep 6;17(36):20262.

16.

Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer.

Rogenhofer S, Ellinger J, Kahl P, Stoehr C, Hartmann A, Engehausen D, Wieland WF, Müller SC, Hofstädter F, Walter B.

Anticancer Res. 2012 Aug;32(8):3479-83.

PMID:
22843934
17.

Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma.

Adam AC, Faudou V, Paschen SA, Adam OM, Kahl P, Drebber U, Fischer HP, Büttner R.

J Pathol. 2012 Nov;228(3):333-40. doi: 10.1002/path.4060. Epub 2012 Jul 3.

PMID:
22685011
18.

Classifying prostate cancer malignancy by quantitative histomorphometry.

Loeffler M, Greulich L, Scheibe P, Kahl P, Shaikhibrahim Z, Braumann UD, Kuska JP, Wernert N.

J Urol. 2012 May;187(5):1867-75. doi: 10.1016/j.juro.2011.12.054. Epub 2012 Mar 16.

PMID:
22424674
19.

Alterations of global histone H4K20 methylation during prostate carcinogenesis.

Behbahani TE, Kahl P, von der Gathen J, Heukamp LC, Baumann C, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Ellinger J.

BMC Urol. 2012 Mar 13;12:5. doi: 10.1186/1471-2490-12-5.

20.

Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma.

Rogenhofer S, Kahl P, Holzapfel S, VON Ruecker A, Mueller SC, Ellinger J.

Anticancer Res. 2012 Mar;32(3):879-86.

PMID:
22399607
21.

Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.

Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S.

Cancer Invest. 2012 Feb;30(2):92-7. doi: 10.3109/07357907.2011.636117. Epub 2011 Dec 7.

PMID:
22149091
22.

Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors.

Rahner N, Brockschmidt FF, Steinke V, Kahl P, Becker T, Vasen HF, Wijnen JT, Tops CJ, Holinski-Feder E, Ligtenberg MJ, Spruijt L, Görgens H, Stemmler S, Kloor M, Dietmaier W; Dutch Cancer Genetics Group, Schumacher J, Nöthen MM, Propping P.

Fam Cancer. 2012 Mar;11(1):19-26. doi: 10.1007/s10689-011-9489-z.

PMID:
22086303
23.

FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.

Gullotti L, Czerwitzki J, Kirfel J, Propping P, Rahner N, Steinke V, Kahl P, Engel C, Schüle R, Buettner R, Friedrichs N.

Lab Invest. 2011 Dec;91(12):1695-705. doi: 10.1038/labinvest.2011.109. Epub 2011 Aug 8.

24.

Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.

Rogenhofer S, Kahl P, Mertens C, Hauser S, Hartmann W, Büttner R, Müller SC, von Ruecker A, Ellinger J.

BJU Int. 2012 Feb;109(3):459-65. doi: 10.1111/j.1464-410X.2011.10278.x. Epub 2011 Aug 2.

25.

Macroscopic and histopathologic findings in a laparoschisis model in fetal sheep: comparisons with gastroschisis in human fetuses and implications for prenatal interventions.

Kahl P, Buettner R, Tchatcheva K, Stressig R, Gembruch U, Kohl T.

Arch Gynecol Obstet. 2012 Jan;285(1):15-9. doi: 10.1007/s00404-011-1890-1. Epub 2011 Mar 31.

PMID:
21451994
26.

Colonic anastomotic healing in the context of altered macrophage function and endotoxemia.

Pantelis D, Beissel A, Kahl P, Vilz TO, Stoffels B, Wehner S, Kalff JC.

Int J Colorectal Dis. 2011 Jun;26(6):737-46. doi: 10.1007/s00384-011-1171-2. Epub 2011 Mar 15.

PMID:
21404056
27.

Recurrence and variability of germline EPCAM deletions in Lynch syndrome.

Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ.

Hum Mutat. 2011 Apr;32(4):407-14. doi: 10.1002/humu.21446. Epub 2011 Mar 1.

PMID:
21309036
28.

Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma.

Bachmann HS, Heukamp LC, Schmitz KJ, Hilburn CF, Kahl P, Buettner R, Nückel H, Eisenhardt A, Rübben H, Schmid KW, Siffert W, Eggert A, Schramm A, Schulte JH.

Int J Cancer. 2011 Nov 15;129(10):2390-9. doi: 10.1002/ijc.25904. Epub 2011 Mar 25.

29.

DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.

Mirchev MB, Kahl P, Friedrichs N, Kotzev IA, Buettner R.

Folia Med (Plovdiv). 2010 Apr-Jun;52(2):22-30.

PMID:
20836393
30.

Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma.

Mosashvilli D, Kahl P, Mertens C, Holzapfel S, Rogenhofer S, Hauser S, Büttner R, Von Ruecker A, Müller SC, Ellinger J.

Cancer Sci. 2010 Dec;101(12):2664-9. doi: 10.1111/j.1349-7006.2010.01717.x. Epub 2010 Sep 1.

31.

The effect of sealing with a fixed combination of collagen matrix-bound coagulation factors on the healing of colonic anastomoses in experimental high-risk mice models.

Pantelis D, Beissel A, Kahl P, Wehner S, Vilz TO, Kalff JC.

Langenbecks Arch Surg. 2010 Nov;395(8):1039-48. doi: 10.1007/s00423-010-0703-5. Epub 2010 Aug 1.

PMID:
20680329
32.

Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.

König K, Diehl L, Rommerscheidt-Fuss U, Golletz C, Quast T, Kahl P, Kolanus W, Knolle P, Buettner R, Heukamp LC.

J Immunol. 2010 Aug 1;185(3):1466-75. doi: 10.4049/jimmunol.0903449. Epub 2010 Jun 30.

33.

DNA hypermethylation in papillary renal cell carcinoma.

Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ.

BJU Int. 2011 Feb;107(4):664-9. doi: 10.1111/j.1464-410X.2010.09468.x.

34.

Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.

Metzger E, Imhof A, Patel D, Kahl P, Hoffmeyer K, Friedrichs N, Müller JM, Greschik H, Kirfel J, Ji S, Kunowska N, Beisenherz-Huss C, Günther T, Buettner R, Schüle R.

Nature. 2010 Apr 1;464(7289):792-6. doi: 10.1038/nature08839. Epub 2010 Mar 14.

PMID:
20228790
35.

Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma.

Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Büttner R, Müller SC, von Ruecker A.

Int J Cancer. 2010 Nov 15;127(10):2360-6. doi: 10.1002/ijc.25250.

36.

Transient perioperative pharmacologic inhibition of muscularis macrophages as a target for prophylaxis of postoperative ileus does not affect anastomotic healing in mice.

Pantelis D, Kabba MS, Kirfel J, Kahl P, Wehner S, Buettner R, Hirner A, Kalff JC.

Surgery. 2010 Jul;148(1):59-70. doi: 10.1016/j.surg.2009.12.010. Epub 2010 Feb 12.

PMID:
20153496
37.

Expression and mutational status of PDGFR in thymic tumours.

Meister M, Kahl P, Muley T, Morresi-Hauf A, Sebening C, Kern MA, Breinig M, Schnabel P, Dienemann H, Schirmacher P, Rieker RJ.

Anticancer Res. 2009 Oct;29(10):4057-61.

38.

Global levels of histone modifications predict prostate cancer recurrence.

Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, von Ruecker A.

Prostate. 2010 Jan 1;70(1):61-9. doi: 10.1002/pros.21038.

PMID:
19739128
39.

Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening.

Hüneburg R, Lammert F, Rabe C, Rahner N, Kahl P, Büttner R, Propping P, Sauerbruch T, Lamberti C.

Endoscopy. 2009 Apr;41(4):316-22. doi: 10.1055/s-0028-1119628. Epub 2009 Apr 1.

PMID:
19340735
40.

Is there a therapeutic role for fetoscopic surgery in the prenatal treatment of gastroschisis? A feasibility study in sheep.

Kohl T, Tchatcheva K, Stressig R, Gembruch U, Kahl P.

Surg Endosc. 2009 Jul;23(7):1499-505. doi: 10.1007/s00464-009-0394-6. Epub 2009 Mar 5.

PMID:
19263117
41.

Saturation biopsy improves preoperative Gleason scoring of prostate cancer.

Kahl P, Wolf S, Adam A, Heukamp LC, Ellinger J, Vorreuther R, Solleder G, Buettner R.

Pathol Res Pract. 2009;205(4):259-64. doi: 10.1016/j.prp.2008.10.010. Epub 2008 Dec 21.

PMID:
19106019
42.

Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling.

Zimmer S, Kahl P, Buhl TM, Steiner S, Wardelmann E, Merkelbach-Bruse S, Buettner R, Heukamp LC.

J Cancer Res Clin Oncol. 2009 May;135(5):723-30. doi: 10.1007/s00432-008-0509-9. Epub 2008 Nov 11.

PMID:
19002495
43.

Impaired intestinal wound healing in Fhl2-deficient mice is due to disturbed collagen metabolism.

Kirfel J, Pantelis D, Kabba M, Kahl P, Röper A, Kalff JC, Buettner R.

Exp Cell Res. 2008 Dec 10;314(20):3684-91. doi: 10.1016/j.yexcr.2008.09.023. Epub 2008 Oct 10.

PMID:
18950620
44.

Spatial and temporal dynamics of innervation during the development of fetal human pancreas.

Amella C, Cappello F, Kahl P, Fritsch H, Lozanoff S, Sergi C.

Neuroscience. 2008 Jul 17;154(4):1477-87. doi: 10.1016/j.neuroscience.2008.04.050. Epub 2008 May 2.

PMID:
18538483
45.

Orofaciodigital syndrome Type IV (Mohr-Majewski): early prenatal diagnosis in siblings.

Rösing B, Kempe A, Berg C, Kahl P, Knöpfle G, Gembruch U, Geipel A.

Ultrasound Obstet Gynecol. 2008 Apr;31(4):457-60. doi: 10.1002/uog.5285.

46.

Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity.

Ellinger J, Bastian PJ, Ellinger N, Kahl P, Perabo FG, Büttner R, Müller SC, Ruecker Av.

Cancer Lett. 2008 Jun 18;264(2):274-80. doi: 10.1016/j.canlet.2008.01.038. Epub 2008 Mar 10.

PMID:
18329789
47.

CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.

Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.

Urology. 2008 Jan;71(1):161-7. doi: 10.1016/j.urology.2007.09.056.

PMID:
18242387
48.

Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.

Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ.

J Urol. 2008 Jan;179(1):346-52. Epub 2007 Nov 19.

PMID:
18006010
49.

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.

Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.

Prostate. 2008 Jan 1;68(1):42-9.

PMID:
18004747
50.

c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.

Biermann K, Göke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H, Büttner R.

J Pathol. 2007 Nov;213(3):311-8.

PMID:
17768701

Supplemental Content

Support Center